Physician profile
Jennifer Marie Woods
NPI 1801815170
$19,325.56
in general payments reported to CMS, 2019-2025
71 companies · $4,242 in 2025
The $4,242 reported for 2025 was more than what 98% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,044 · 2022: $3,845 · 2023: $3,295 · 2024: $4,901 · 2025: $4,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $1,070 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,143.35 |
| Consulting Fee | $1,070.00 |
| Education | $223.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $1,711.07 | 2021-2025 | Ultomiris, Soliris |
| Abbvie INC. | $1,441.21 | 2021-2025 | |
| Biogen, INC. | $1,080.41 | 2021-2025 | Tysabri, Vumerity |
| Novartis Pharmaceuticals Corporation | $1,078.58 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $917.53 | 2021-2025 | |
| Ucb, INC. | $866.92 | 2021-2025 | Briviact, Nayzilam, Zilbrysq |
| Harmony Biosciences LLC | $792.05 | 2022-2025 | Wakix |
| Genzyme Corporation | $725.53 | 2021-2025 | |
| Sk Life Science, INC. | $719.01 | 2021-2025 | Xcopri |
| Emd Serono, INC. | $670.61 | 2021-2025 | Mavenclad |
| Takeda Pharmaceuticals U.S.A., INC. | $577.92 | 2021-2025 | Entyvio, Gattex |
| Neurocrine Biosciences, INC. | $555.50 | 2021-2025 | Ingrezza |
| Genentech USA, INC. | $518.82 | 2021-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Acadia Pharmaceuticals INC | $498.92 | 2023-2025 | Nuplazid, Daybue |
| Inspire Medical Systems, INC. | $478.34 | 2022-2024 | Inspire |
Show all 71 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.